114 related articles for article (PubMed ID: 8679539)
1. Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta.
Chan W; Fornwald J; Brawner M; Wetzel R
Biochemistry; 1996 Jun; 35(22):7123-30. PubMed ID: 8679539
[TBL] [Abstract][Full Text] [Related]
2. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
4. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
Wood SJ; Chan W; Wetzel R
Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
[TBL] [Abstract][Full Text] [Related]
5. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
6. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
7. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
Golabek AA; Soto C; Vogel T; Wisniewski T
J Biol Chem; 1996 May; 271(18):10602-6. PubMed ID: 8631862
[TBL] [Abstract][Full Text] [Related]
8. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease.
Pillot T; Goethals M; Najib J; Labeur C; Lins L; Chambaz J; Brasseur R; Vandekerckhove J; Rosseneu M
J Neurochem; 1999 Jan; 72(1):230-7. PubMed ID: 9886074
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.
Zhou Z; Smith JD; Greengard P; Gandy S
Mol Med; 1996 Mar; 2(2):175-80. PubMed ID: 8726460
[TBL] [Abstract][Full Text] [Related]
12. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
Miida T; Yamada T; Seino U; Ito M; Fueki Y; Takahashi A; Kosuge K; Soda S; Hanyu O; Obayashi K; Miyazaki O; Okada M
Biochim Biophys Acta; 2006 Apr; 1761(4):424-33. PubMed ID: 16651021
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.
Haas C; Cazorla P; Miguel CD; Valdivieso F; Vázquez J
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):169-75. PubMed ID: 9224643
[TBL] [Abstract][Full Text] [Related]
16. Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E.
Golabek AA; Kida E; Walus M; Perez C; Wisniewski T; Soto C
Biophys J; 2000 Aug; 79(2):1008-15. PubMed ID: 10920030
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
Morrow JA; Arnold KS; Weisgraber KH
Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
[TBL] [Abstract][Full Text] [Related]
18. Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.
Zhou Z; Relkin N; Ghiso J; Smith JD; Gandy S
Mol Med; 2002 Jul; 8(7):376-81. PubMed ID: 12393935
[TBL] [Abstract][Full Text] [Related]
19. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms.
Pillot T; Goethals M; Vanloo B; Lins L; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Feb; 243(3):650-9. PubMed ID: 9057828
[TBL] [Abstract][Full Text] [Related]
20. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro.
Naiki H; Gejyo F; Nakakuki K
Biochemistry; 1997 May; 36(20):6243-50. PubMed ID: 9166797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
